Trials / Completed
CompletedNCT00854607
An Observational Study of Fungal Biomarkers (MK-0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 116 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the relationship between fungal biomarker levels during anti-fungal therapy and the success of treatment for fungal infection. The primary hypothesis is that over the initial two weeks of anti-fungal therapy, fungal biomarkers from participants with invasive aspergillosis (IA) will be lower for those with a successful clinical outcome compared to those with a failed clinical outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | Blood samples will be collected for 12 weeks to evaluate levels of fungal biomarkers. |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-06-01
- Completion
- 2011-08-01
- First posted
- 2009-03-03
- Last updated
- 2015-08-21
- Results posted
- 2012-08-28
Source: ClinicalTrials.gov record NCT00854607. Inclusion in this directory is not an endorsement.